WKK INTL (HOLD)(00532): Wang Zhongtong has been transferred to the position of non-executive director.

18:39 03/08/2026

WKK INTL (HOLD)(00532) announced that Mr. Wang Zhongtong, Chairman of the Board and Executive Director, has been appointed as the Honorary Chairman of the company and will be transferred to a Non-Executive Director role effective August 3, 2026, in recognition of his invaluable contributions to the group over many years in his capacity as Chairman.

WKK INTL (HOLD) (00532) announced that Mr. Wang Zhongtong, the Chairman of the Board and Executive Director, has been appointed as the Honorary Chairman of the company and will be transferred to Non-Executive Director, effective August 3, 2026, in recognition of his valuable contributions to the Group over many years in his role as Chairman.

KEEN OCEAN (08070) has issued a positive profit alert, expecting a mid-term net profit of approximately HKD 23 million, an increase of about 161.4% year-on-year.

CSPC PHARMA (01093): The Phase Ib/II clinical trial of SYS 6090 injection for the treatment of colorectal cancer has officially launched at the first research center in China.

WuXi AppTec (603259.SH) plans to launch an A-share employee stock ownership plan in 2026.

KEEN OCEAN (08070) has issued a positive profit alert, expecting a mid-term net profit of approximately HKD 23 million, an increase of about 161.4% year-on-year.

CSPC PHARMA (01093): The Phase Ib/II clinical trial of SYS 6090 injection for the treatment of colorectal cancer has officially launched at the first research center in China.

WuXi AppTec (603259.SH) plans to launch an A-share employee stock ownership plan in 2026.